Hainan Haiyao Co Ltd - Asset Resilience Ratio
Hainan Haiyao Co Ltd (000566) has an Asset Resilience Ratio of 3.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1993–2024)
This chart shows how Hainan Haiyao Co Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Hainan Haiyao Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Hainan Haiyao Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hainan Haiyao Co Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥189.11 Million | 3.27% |
| Total Liquid Assets | CN¥189.11 Million | 3.27% |
Asset Resilience Insights
- Limited Liquidity: Hainan Haiyao Co Ltd maintains only 3.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hainan Haiyao Co Ltd Industry Peers by Asset Resilience Ratio
Compare Hainan Haiyao Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621 |
Drug Manufacturers - Specialty & Generic | 2.04% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
|
Jw Pharmac
KO:001060 |
Drug Manufacturers - Specialty & Generic | 3.65% |
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Samjin Pharm
KO:005500 |
Drug Manufacturers - Specialty & Generic | 0.25% |
Annual Asset Resilience Ratio for Hainan Haiyao Co Ltd (1993–2024)
The table below shows the annual Asset Resilience Ratio data for Hainan Haiyao Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.14% | CN¥192.06 Million ≈ $28.10 Million |
CN¥6.11 Billion ≈ $894.60 Million |
-4.54pp |
| 2023-12-31 | 7.68% | CN¥566.02 Million ≈ $82.83 Million |
CN¥7.37 Billion ≈ $1.08 Billion |
-0.19pp |
| 2022-12-31 | 7.87% | CN¥580.00 Million ≈ $84.87 Million |
CN¥7.37 Billion ≈ $1.08 Billion |
-2.24pp |
| 2021-12-31 | 10.11% | CN¥845.87 Million ≈ $123.78 Million |
CN¥8.36 Billion ≈ $1.22 Billion |
-6.33pp |
| 2020-12-31 | 16.45% | CN¥1.69 Billion ≈ $247.38 Million |
CN¥10.28 Billion ≈ $1.50 Billion |
+2.11pp |
| 2019-12-31 | 14.34% | CN¥1.55 Billion ≈ $226.10 Million |
CN¥10.78 Billion ≈ $1.58 Billion |
+13.81pp |
| 2018-12-31 | 0.53% | CN¥54.27 Million ≈ $7.94 Million |
CN¥10.34 Billion ≈ $1.51 Billion |
-2.25pp |
| 2017-12-31 | 2.78% | CN¥293.17 Million ≈ $42.90 Million |
CN¥10.55 Billion ≈ $1.54 Billion |
+2.26pp |
| 2016-12-31 | 0.52% | CN¥50.37 Million ≈ $7.37 Million |
CN¥9.61 Billion ≈ $1.41 Billion |
+5.38pp |
| 2015-12-31 | -4.85% | CN¥-236.90 Million ≈ $-34.67 Million |
CN¥4.88 Billion ≈ $714.42 Million |
-5.58pp |
| 2012-12-31 | 0.72% | CN¥20.00 Million ≈ $2.93 Million |
CN¥2.76 Billion ≈ $404.10 Million |
+0.40pp |
| 2010-12-31 | 0.33% | CN¥3.52 Million ≈ $514.36K |
CN¥1.08 Billion ≈ $157.78 Million |
+0.30pp |
| 2009-12-31 | 0.03% | CN¥232.99K ≈ $34.09K |
CN¥845.06 Million ≈ $123.66 Million |
+0.01pp |
| 2008-12-31 | 0.02% | CN¥144.30K ≈ $21.12K |
CN¥734.56 Million ≈ $107.49 Million |
-2.52pp |
| 1996-12-31 | 2.54% | CN¥24.17 Million ≈ $3.54 Million |
CN¥953.11 Million ≈ $139.47 Million |
+0.84pp |
| 1995-12-31 | 1.70% | CN¥14.31 Million ≈ $2.09 Million |
CN¥844.05 Million ≈ $123.51 Million |
-5.41pp |
| 1994-12-31 | 7.10% | CN¥55.95 Million ≈ $8.19 Million |
CN¥787.46 Million ≈ $115.23 Million |
+6.34pp |
| 1993-12-31 | 0.76% | CN¥4.45 Million ≈ $650.74K |
CN¥583.44 Million ≈ $85.38 Million |
-- |
About Hainan Haiyao Co Ltd
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective product… Read more